OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim, Quarraisha Abdool Karim
The Lancet (2021) Vol. 398, Iss. 10317, pp. 2126-2128
Open Access | Times Cited: 1289

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305

A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants
Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 112

Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021
Christopher B. Forrest, Evanette Burrows, Asunción Mejías, et al.
PEDIATRICS (2022) Vol. 149, Iss. 4
Open Access | Times Cited: 88

The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues
Naushad Ahmad Khan, Hassan Al‐Thani, Ayman El‐Menyar
Travel Medicine and Infectious Disease (2021) Vol. 45, pp. 102246-102246
Open Access | Times Cited: 67

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Zhenhao Fang, Lei Peng, Renata B. Filler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Kerstin Kläser, Erika Molteni, Mark S. Graham, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 50

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
Kai-Wei K. Chen, Daniel Tsung‐Ning Huang, Li‐Min Huang
Biomedical Journal (2022) Vol. 45, Iss. 4, pp. 573-579
Open Access | Times Cited: 49

Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010802-e1010802
Open Access | Times Cited: 46

Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants
Hannah W. Despres, Margaret G. Mills, David J. Shirley, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 5
Open Access | Times Cited: 43

Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant
Erika Molteni, Carole H. Sudre, Liane S. Canas, et al.
Children (2022) Vol. 9, Iss. 5, pp. 652-652
Open Access | Times Cited: 41

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, et al.
Science Immunology (2022) Vol. 7, Iss. 72
Open Access | Times Cited: 37

Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion
Li Shen, Timothy J. Triche, Jennifer Dien Bard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 51

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49

Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform
Changsheng He, Cailing Lin, Guosheng Mo, et al.
Biosensors and Bioelectronics (2021) Vol. 198, pp. 113857-113857
Open Access | Times Cited: 41

Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals
Stijn P. Andeweg, Harry Vennema, Irene Veldhuijzen, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 684
Open Access | Times Cited: 33

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial
Rolando Pajón, Yamuna Devi Paila, Bethany Girard, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 823-830
Open Access | Times Cited: 32

SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access

Patient coordination during the COVID-19 pandemic in the Amsterdam region: effects on capacity utilization and patient flow
Eva Berkeveld, Martijn D.F. Rhebergen, Frank W. Bloemers, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access

Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 37

Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
Erika Molteni, Carole H. Sudre, Liane S. Canas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top